Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Today’s video why tetra is different

<< Previous

Bullboard Posts

Next >>

Comment by Kingofstockston Nov 03, 2021 8:44am

79 Views

Post# 34081160

RE:RE:RE:Today’s video why tetra is different

Look at the names Tetra was included with, something great is happening At present, the market is sharping its presence and some of the key players in the study are Actimed Therapeutics, Anuh Pharma Ltd., Aphios Corporation, Aveo Oncology, Fresenius Kabi, Helsinn Group, Merck KGaA, NGM Biopharmaceuticals, Pfizer Inc., R&D Systems Inc., Symbiotec Pharma Lab Pvt. Ltd., and Tetra Bio-Pharma amongst others. The study is a perfect mix of qualitative and quantitative Market data collected and validated majorly through primary data and secondary sources.

<< Previous

Bullboard Posts

Next >>

The top 10 Canadian medical stocks